Alnylam Pharmaceuticals, Inc.
Time frame: 1 February 2023 - 31 January 2024Article ‘Count’ and ‘Share’ for Alnylam Pharmaceuticals, Inc. based on listed parameters only.
The articles listed below published by authors from Alnylam Pharmaceuticals, Inc., organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
Chemical Communications |
1 | 0.91 |
JAMA: The Journal of the American Medical Association |
1 | 0.02 |
Journal of Hepatology |
1 | 0.16 |
Journal of the American Chemical Society |
1 | 0.81 |
Nature |
1 | 0.07 |
Nature Communications |
1 | 1.00 |
Organic Letters |
1 | 0.38 |
The New England Journal of Medicine |
2 | 0.76 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.